Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 18, 2022

Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al

Track this case

Case Number:

1:22-cv-02229

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Mary Kay Vyskocil

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 05, 2022

    Developers Tied To Pfizer COVID Vaccine Want IP Suit Tossed

    Two developers of the mRNA delivery system used in Pfizer and BioNTech's COVID-19 vaccine have urged a New York federal judge to toss a suit from Acuitas Therapeutics Inc. seeking a declaration that the sale of Pfizer's COVID-19 Comirnaty vaccine does not infringe nine of the developers' patents.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login